Standard BioTools (LAB) - Prakiraan volume dodolan
Diversifying electronics suppliers beyond Asia stabilizes system production, as confirmed by Standard BioTools Inc. (LAB) sales volume expectations. Growth is driven by reagent sales and the CyTOF base, while new management optimizes costs. The indicator's price action reflects a balanced valuation, where 0.08 serves as the final level mark.
Rincian analitis perusahaan Standard BioTools Inc.
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi pasar:
- informasi kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Standard BioTools Inc.|LAB - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Fluidigm|LAB - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Standard BioTools Inc|LAB - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Standard BioTools|Rasio cepet fluidigm.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
LAB - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep Standard BioTools Inc.|LAB - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Standard BioTools|LAB - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Standard BioTools Inc|LAB - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Standard BioTools|LAB - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan fluidigm.com|LAB - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Standard BioTools Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Pambiji fundamental:Standard BioTools Inc.
Expected sales volume measures business expansion potential and the alignment of assets with capitalization standards, capturing shifts in the issuer's commercial prospects without a time lag. By analyzing the projected sales dynamics of Standard BioTools Inc. (LAB) on GURU.Markets, an investor assesses the impact of diversifying electronics supply chains outside of Asia on the stability of system assembly and ultimate revenue growth.
Karo sapa Standard BioTools Inc. saingan
Volume dodolan mangsa ngarep perusahaan A (Agilent Technologies)|Prakiraan volume pendapatan perusahaan DGX|Prakiraan volume dodolan ILMN (Illumina)|Prakiraan volume dodolan Exact Sciences Corp EXAS|RVTY - Prakiraan pendapatan perusahaan|BIO (Bio-Rad Corp) - Prakiraan pendapatan perusahaan|NNNN: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan SHC|QDEL (QuidelOrtho Corporation) - Prakiraan volume dodolan|Prakiraan volume dodolan OPKO Health Inc|Prakiraan pendapatan perusahaan CareDx Corp (CDNA)|MRVI (Maravai) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan FLGT (Fulgent Genetics, Inc.)|CTKB: Prakiraan pendapatan perusahaan|OSUR: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan XGN (Exagen Inc.)|MDXH: Prakiraan volume dodolan|LUCD (Lucid Diagnostics, Inc) - Prakiraan pendapatan perusahaan|PRE (Prenetics Global Limited) - Prakiraan volume dodolan|Insight Molecular (IMDX) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Trinity Biotech plc (TRIB)|PRPH - Volume dodolan sing dikarepake perusahaan|Ainos Corp - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan CODX (CoDx)|HSCS - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan biomerica.com|cardiodiagnosticsinc.com (CDIO) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Onconetix Inc (ONCO)|Prakiraan pendapatan perusahaan Virax Biolabs Group Ltd|Prakiraan pendapatan perusahaan BJDX|Prakiraan pendapatan perusahaan Aspira Women's Health (AWH)|Dodolan mangsa ngarep perusahaan acceleratediagnostics.com|Centogene - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan ENZ|Fresh2 - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan Genetic Technologies GENE|23andMe Holding Co. (ME) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan PMD
